Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 1-2, 2004, Pages 65-69

  Lin, Chun Ching ^a,c   Ng, Lean Teik ^d   Hsu, Fen Fang ^a   Shieh, Den En ^b,d   Chiang, Lien Chai ^c  

^a Grad Institute of Natural Products   (Taiwan)

^b Graduate Institute of Medical Genomics and Proteomics   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Antihepatoma; Antileukaemia; Berberine; Coptis chinensis; Coptisine; Epimedium sagittatum; Icariin

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE; COPTIS CHINENSIS EXTRACT; COPTISINE; EPIMEDIUM SAGITTATUM EXTRACT; ICARIIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; COPTIS CHINENSIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; EPIMEDIUM SAGITTATUM; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; LIVER CELL CARCINOMA; MEDICINAL PLANT;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COPTIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIMEDIUM; FLAVONOIDS; FLUOROURACIL; HUMANS; LEUKEMIA, EXPERIMENTAL; PLANT EXTRACTS; SOLUTIONS;

EID: 1242337439     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03951.x     Document Type: Article

References (22)

1. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology 1992; 15: 948-63.
2. Tong MJ, Weiner JM, Ashcavai MW, Redeker AG, Comparini S, Vyas GN. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J. Infect. Dis. 1979; 140: 506-12.
3. Lau BH, Ruckle HC, Botolazzo T, Lui PD. Chinese medicinal herbs inhibit growth of murine renal cell carcinoma. Cancer Biother. 1994; 9: 153-61.
4. Xiao PG, Lian WY. The Illustrated Medicinal Plants of China, Vol. 1. SMC Publishing: Taipei. 1998.
5. Liu F, Ng TB. Antioxidative and free radical scavenging activities of selected medicinal herbs. Life Sci. 2000; 66: 725-35.
6. Schinella GR, Tournier HA, Prieto JM, Mordujovich D, Rios JL. Antioxidant activity of anti-inflammatory plant extracts. Life Sci. 2002; 70: 1023-33.
7. Anonymous. Berberine. Altern. Med. Rev. 2000; 5: 175-7.
8. Kuo CL, Chou CC, Yung BY. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 1995; 93: 193-200.
9. Wu HL, Hsu CY, Liu WH, Yung BY. Berberine-induced apoptosis of human leukaemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int. J. Cancer 1999; 81: 923-9.
10. Lin HL, Liu TY, Lui WY, Chi CW. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer 1999; 85: 1937-42.
11. He W, Sun H, Yang B, Zhang D, Kabelitz D. Immunoregulatory effects of the herb Epimediia glycoside icariin. Arzneimittelforschung 1995; 45: 910-13.
12. Lee MK, Choi YJ, Sung SH, Shin DI, Kim JW, Kim YC. Antihepatotoxic activity of icariin, a major constituent of Epimedium koreanum. Planta Med. 1995; 61: 523-6.
13. Liao HJ, Chen XM, Li WG. Effect of Epimedium sagittatum on quality of life and cellular immunity in patients of hemodialysis maintenance. Chung Kuo Chung Hsi Chieh Ho Tsa Chih 1995; 15: 202-4 (in Chinese).
14. Linuma M, Tanaka T, Sakakibara N et al. Phagocytic activity of leaves of Epimedium species on mouse reticuloendotherial system. Yakugaku Zasshi 1990; 110: 179-85 (in Japanese).
15. Scudiero DA, Shoemaker RH, Paull KD et al. Evaluation of a soluble tetrazolium/formazam assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988; 48: 4827-33.
16. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. Immunol. Methods 1991; 142: 257-65.
17. Chen PL, Chen YM, Bookstein R, Lee WH. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990; 250: 1576-80.
18. Finlay CA, Hinds PW, Lewine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-93.
19. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-31.
20. Marin-Neto JA, Maciel BC, Secches AL, Gallo Junior L. Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin. Cardiol. 1988; 11: 252-60.
21. Ghosh AK, Bhattacharyya FK, Ghosh DK. Amastigote inhibition and mode of action of berberine. Exp. Parasitol. 1985; 60: 404-13.
22. Rozenszajn LA, Firestein F, Ashush H et al. Therapeutic ultrasound induces apoptosis in p53 positive and p53 negative malignant hemopoietic cell lines. Exp. Hematol. 2000; 28: 1503.